Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial ...
Discover Merck's groundbreaking patent on genetic markers linked to enhanced C. difficile treatment responses. Learn how personalized therapy can improve patient outcomes.
Here is a list of FDA-approved nucleoside reverse transcriptase inhibitors and the year they were approved: Protease inhibitors are drugs used to treat HIV, along with viral infections such as ...
The program focuses on preventing infections and medication errors in IV therapy. Since its inception in 2019, the PRIME Program has been implemented in 30 hospitals across India. The initiative ...
Mild Clostridium difficile infection (CDI; stool frequency <four ... and place on therapy immediately if this occurs. Treatment for an initial episode and a first recurrence of CDI: If oral ...
diff., a bacterium that can cause serious infections in the colon. Symptoms can range from mild diarrhea and stomach pain to significant colon damage, which can sometimes require surgery. “Antibiotics ...